QART Medical

Enabling highly informed sperm selection to dramatically improve IVF success

QART Medical’s breakthrough product is positioned to reshape the practice of IVF by providing embryologists with deep, objective, and quantitative information into individual sperm cells that are to be injected into the oocytes (eggs). With proprietary holographic imaging, machine vision, and cutting-edge image processing algorithms, QART characterizes the properties of individual sperm cells relative to consensus world-health-organization criteria in real-time. This is evidence-based medicine in male fertility, at its best.

QART Medical logo

CEO
Alon Shalev

FROM
Raanana, Israel

SOCIAL

WATCH THE OVERVIEW